Analyst Ratings February 10, 2026

Morgan Stanley Lowers Saia Rating to Underweight, Flags Valuation as Key Risk

Analyst cuts to Underweight and $250 price target underscore concerns after Q4 results deemed a modest miss despite upbeat Q1 guidance

By Ajmal Hussain SAIA
Morgan Stanley Lowers Saia Rating to Underweight, Flags Valuation as Key Risk
SAIA

Morgan Stanley downgraded Saia Inc. (SAIA) from Equalweight to Underweight and set a $250 price target, citing a stretched valuation despite a mixed fourth-quarter report. The firm highlighted that earnings estimates have fallen sharply over the last year while the share price has climbed, leaving a risk-reward profile skewed to the downside according to the bank.

Key Points

  • Morgan Stanley downgraded Saia from Equalweight to Underweight and set a $250 price target, below the prevailing market price.
  • The bank labeled Saia's Q4 results a "modest miss" despite the company offering "relatively optimistic" first-quarter guidance; consensus estimates are not expected to change materially.
  • Valuation is the central concern: earnings estimates have been nearly halved over the past year even as the stock has traded above $400, with a P/E around 37.04 and an estimated FY2026 P/E near 40.

Morgan Stanley has moved Saia Inc. (NASDAQ: SAIA) off its Equalweight list and into an Underweight designation, putting a $250.00 price target on the less-than-truckload carrier - a valuation markedly below the stock's most recent quote of $390.47.

The downgrading followed Saia's fourth-quarter financial report, which Morgan Stanley characterized as a "modest miss." Management issued guidance the firm described as "relatively optimistic" for the first quarter, but analysts at Morgan Stanley concluded that the company’s quarterly disclosure was not strong enough to justify the current share price.

In its note, Morgan Stanley indicated it did not expect consensus estimates to move meaningfully in reaction to the quarterly release. Instead, the bank focused on valuation metrics and the disconnect between the company’s diminished earnings trajectory and its market valuation.

Morgan Stanley emphasized that Saia’s stock has again traded above $400 per share even though the firm says earnings estimates for the company have been "nearly halved over the past year." Supporting that view, InvestingPro data cited by Morgan Stanley shows Saia changing hands at a price-to-earnings ratio of 37.04 and trading above its calculated Fair Value.

The bank further estimated Saia will trade at roughly 40 times projected fiscal year 2026 earnings, concluding that the risk-reward profile appears "skewed to the downside, even in an upcycle." The equity’s recent market behavior - including a beta of 2.08 and a one-week return of 9.44% - reinforced concerns about volatility and valuation in Morgan Stanley’s assessment.

Saia’s published fourth-quarter results showed mixed outcomes. The company reported earnings per share of $1.77, missing the consensus estimate of $1.90. Management said the shortfall reflected $4.7 million of adverse prior period accident claims development, which reduced EPS by $0.14. Revenues, however, came in at $790 million versus expectation of $775.64 million.

The earnings shortfall prompted at least one other analyst to adjust expectations; Stifel trimmed its price target to $364 from $371 while keeping a Hold rating. Those moves reflect investor caution around Saia amid the recent financial update and the valuation questions flagged by Morgan Stanley.


Note: Where available data is limited, this article reflects only the information provided in the company disclosures and analyst notes referenced above.

Risks

  • High valuation relative to reduced earnings estimates increases downside risk for shareholders in the transportation and logistics sector.
  • Elevated share price volatility - reflected in a beta of 2.08 and recent strong short-term returns - may amplify investor losses during market swings.
  • Earnings sensitivity to one-time or prior-period adjustments, such as the $4.7 million adverse accident claims development, can materially affect reported EPS and analyst outlooks, influencing capital markets sentiment.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026